Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

News > All

Total search results: 16981 | Ordered by Source (ascending)
next pagenext page 1 2 3 ... 168 169 170  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
4SC AG. (5/30/13). "Press Release: 4SC Gives Update on the Clinical Development of Its Lead Cancer Compound Resminostat". Planegg-Martinsried. 2013-05-30
4SC AG. (5/31/16). "Press Release: 4SC Enters into Licensing and Development Partnership with Link Health for the Cancer Compound 4SC-205 in China". Planegg-Martinsried. 2016-05-31
4SC AG. (5/8/14). "Press Release: 4SC Announces Financial Results for the First Quarter of 2014". Planegg-Martinsried. 2014-05-08
4SC AG. (5/9/11). "Press Release: 4SC’s Vidofludimus Inhibits IL-17 Production by Interference with the JAK/STAT and NF-kB Pathways". Planegg-Martinsried. 2011-05-09
4SC AG. (6/11/13). "Press Release: UCB to Collaborate with Crelux and 4SC Discovery to Meet Unmet Needs in Neurology". Planegg-Martinsried & Brussels. 2013-06-11
4SC AG. (6/20/13). "Press Release: 4SC Announces Restructuring Associated with Recently Declared Strategic Shift". Planegg-Martinsried. 2013-06-20
4SC AG. (6/23/11). "Press Release: 4SC Reports New Data from the Clinical Trials with Oral Pan-HDAC Inhibitor Resminostat. Update on Phase II SHELTER and Phase I/II SHORE Trials". Planegg-Martinsried. 2011-06-23
4SC AG. (6/28/19). "Press Release: 4SC AG Secures EUR 11 Million from Capital Increase [Ad hoc, not for US, AU, CA, JP, ZA, et al.]". Planegg-Martinsried. 2019-06-28
4SC AG. (6/29/12). "Press Release: 4SC AG Capital Increase. Subscription Offer Period Ended, Rump Placement Started [not for USA, Australia, Canada, Japan et al.]". Planegg-Martinsried. 2012-06-29
4SC AG. (6/29/12). "Press Release: 4SC AG. Volume of the Capital Increase Has Been Determined at 8,403,510 New Shares, Gross Proceeds of EUR 12,605,265.00 Expected [not for USA, Australia, Canada, Japan et al.]". Planegg-Martinsried. 2012-06-29
4SC AG. (6/5/14). "Press Release: 4SC Secures Financing with Shareholder Loan of up to EUR 10 Million". 2014-06-05
4SC AG. (6/8/11). "Press Release: 4SC Announces Topline Results of Phase IIb Trial of Vidofludimus in Rheumatoid Arthritis". Planegg-Martinsried. 2011-06-08
4SC AG. (7/12/11). "Press Release: FDA Grants Orphan Drug Designation to 4SC’s Oral Pan-HDAC Inhibitor Resminostat for the Treatment of Hepatocellular Carcinoma". Planegg-Martinsried. 2011-07-12
4SC AG. (7/17/12). "Press Release: 4SC Discovery, Crelux and Ribological Launch Collaboration for the Discovery and Optimisation of New Anti-cancer Drugs [no US". Planegg-Martinsried. 2012-07-17
4SC AG. (7/18/17). "Press Release: 4SC Licenses Kv1.3 Inhibitors to Maruho. Maruho to Receive Exclusive Worldwide License on 4SC’s Preclinical Inhibitors of the Kv1.3 Ion Channel". Planegg-Martinsried. 2017-07-18
4SC AG. (7/20/16). "Press Release: 4SC Forms International Scientific Expert Panel". Planegg-Martinsried. 2016-07-20
4SC AG. (7/24/14). "Press Release: Crelux and 4SC Discovery Awarded Research Grant for New Epigenetic Cancer Drugs. Project for Identifying New Bromodomain Inhibitors Initiated under the Munich m4 Biotech Cluster Programme". Planegg-Martinsried. 2014-07-24
4SC AG. (7/26/11). "Press Release: European Medicines Agency Adopts Positive Opinion for Orphan Medicinal Product Designation for 4SC’s Resminostat to Treat Hepatocellular Carcinoma". 2011-07-26
4SC AG. (7/29/15). "Press Release: 4SC AG Announces Formal Closing of Capital Increase [Not for United States, Australia, Canada or Japan]". Planegg-Martinsried. 2015-07-29
4SC AG. (7/6/17). "Press Release: 4SC AG Secures EUR 41 Million from Successful Capital Increase [Not for US, AU, CA, JP or ZA]". Planegg-Martinsried. 2017-07-06
4SC AG. (7/7/15). "Press Release: 4SC AG Secures EUR 29 Million from Capital Increase to Finance Planned Clinical Development Programme of Its Cancer Compound Resminostat [ Ad hoc release, not for US, AU, CA or JP]". Planegg-Martinsried. 2015-07-07
4SC AG. (8/1/17). "Press Release: 4SC AG Was Granted a Fundamental Composition of Matter Patent for 4SC-208 for the US". Planegg-Martinsried. 2017-08-01
4SC AG. (8/11/16). "Press Release: 4SC Provides Operational and Financial Update for Q2 and 6M 2016". Planegg-Martinsried. 2016-08-11
4SC AG. (8/18/14). "Press Release: Dr Thomas Werner und Klaus Kühn Announce Resignation for Supervisory Board". 2014-08-18
4SC AG. (8/6/12). "Press Release: 4SC AG further Strengthens Supervisory Board with Experienced Managers from the Pharmaceutical Industry [Not for US, AU, CA, JP et al.]". Planegg-Martinsried. 2012-08-06
4SC AG. (8/7/14). "Press Release: 4SC Announces Financial Results for the First Half of 2014". Planegg-Martinsried. 2014-08-07
4SC AG. (8/8/13). "Press Release: 4SC Reports Second Quarter 2013 Financial Results". Planegg-Martinsried. 2013-08-08
4SC AG. (8/9/11). "Press Release: 4SC Announces Financial Results for the Second Quarter and First Half of 2011". Planegg-Martinsried. 2011-08-09
4SC AG. (8/9/12). "Press Release: 4SC’s Successful Start to the Year Continues in Q2 of 2012 [Not for release, publication or distribution in or into US, AU, CA and JP]". Planegg-Martinsried. 2012-08-09
4SC AG. (8/9/18). "Press Release: 4SC Provides Q2 and H1 2018 Update". Planegg-Martinsried. 2018-08-09
4SC AG. (9/16/10). "Press Release: 4SC Provides Enrolment Update for Phase IIb Rheumatoid Arthritis Study with Vidofludimus (4SC-101)". Planegg-Martinsried. 2010-09-16
4SC AG. (9/17/10). "Press Release: 4SC Presents Initial Data from the Resminostat (4SC-201) Phase II SHELTER Study in Hepatocellular Carcinoma (HCC)". Planegg-Martinsried. 2010-09-17
4SC AG. (9/20/18). "Press Release: Domatinostat Plus Chemotherapy – Overcoming Drug Resistance". Planegg-Martinsried. 2018-09-20
4SC AG. (9/21/16). "Press Release: Dr Jason Loveridge Appointed New CEO of 4SC". Planegg-Martinsried. 2016-09-21
4SC AG. (9/26/11). "Press Release: 4SC’s Resminostat Receives FDA Orphan Drug Status for Hodgkin’s Lymphoma". Planegg-Martinsried. 2011-09-26
4SC AG. (9/26/13). "Press Release: 4SC Discovery and Panoptes Pharma Sign Patent Transfer Agreement for Novel Compound to Treat Severe Eye Diseases". Planegg-Martinsried & Vienna. 2013-09-26
4SC AG. (9/3/14). "Press Release: 4SC AG Issues Second Tranche of Convertible Notes with a Nominal Amount of EUR 500,000 to Yorkville". Planegg-Martinsried. 2014-09-03
4SC AG. (9/6/11). "Press Release: 4SC’s Resminostat Meets Primary Efficacy Endpoint in Phase II Trial in Hodgkin’s Lymphoma. Resminostat Shows Substantial Clinical Benefit in Heavily Pre-treated Relapsed/Regractory HL Patients". Planegg-Martinsried. 2011-09-06
7TM Pharma A/S. (2/4/10). "Press Release: 7TM Pharma Successfully Conducts Clinical Phase I Trial with Its Second Generation CB1 Receptor Antagonist". 2010-02-04
908 Devices, Inc.. (3/4/15). "Press Release: 908 Devices Announces International Expansion". 2015-03-04
908 Devices, Inc.. (6/2/16). "Press Release: Thermo Fisher Scientific and 908 Devices to Demonstrate Innovative Separation Technology with Industry-Leading Orbitrap Mass Spectrometers at ASMS 2016". 2016-06-02
908 Devices, Inc.. (6/21/16). "Press Release: 908 Devices Announces Significant Investments for Life Science Division Following Series C Funding Round". Boston, MA. 2016-06-21
908 Devices, Inc.. (6/3/19). "Press Release: 908 Devices Broadens the ZipChip Platform, Brings New Capability to Biotherapeutics Researchers". Boston, MA. 2019-06-03
908 Devices, Inc.. (7/25/19). "Press Release: 908 Devices Poised to Modernize Upstream Bioprocess Analytics with a Grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)". Boston, MA. 2019-07-25
908 Devices, Inc.. (9/11/13). "Press Release: 908 Devices Receives $7 Million in Series B Funding and Signs Multi-year Development Agreement". Boston, MA. 2013-09-11
A*STAR. (1/22/14). "Press Release: A*STAR Signs Agreement with Nestlé to Strengthen Food & Nutrition R&D in Singapore". 2014-01-22
A*STAR. (8/12/10). "Press Release: A*STAR and Institut Mérieux/bioMérieux Invest S$3m in Tuberculosis Research. Partnership Could Lead to Improved Detection and Treatment of the Highly Infectious Disease that Affects Millions Worldwide". 2010-08-12
A-Mansia Biotech S.A.. (4/27/18). "Press Release: Belgian Microbiome Spin-off A-Mansia Announces €13m First Close of Series A Financing". Louvain-la-Neuve. 2018-04-27
A. M. Pappas & Associates. (9/2/14). "Press Release: Chiesi Launches Venture Capital Fund via Strategic Collaboration with A. M. Pappas & Associates. Strategic Collaboration to Focus on Rare Disease Early Stage Investment Opportunities". Parma & Research 2014-09-02
A. Menarini Industrie Farmaceutiche Riunite S.r.l.. (10/29/12). "Press Release: Menarini Group and Oxford BioTherapeutics Sign Major Strategic Collaboration for the Clinical Development and Manufacture of a Portfolio of Novel Antibody-based Cancer Drugs" 2012-10-29
A. Menarini Industrie Farmaceutiche Riunite S.r.l.. (11/25/14). "Press Release: The Menarini Group. New Molecule against Lymphomas and Solid Tumours". Florence. 2014-11-25
A. Menarini Industrie Farmaceutiche Riunite S.r.l.. (11/28/16). "Press Release: Chugai and Berlin-Chemie – the Menarini Group Announce Global License Agreement for an Anti-cancer Agent, PA799". Tokyo & Florence. 2016-11-28
A. Menarini Industrie Farmaceutiche Riunite S.r.l.. (12/20/16). "Press Release: Menarini Acquires CellSearch Business from American group Janssen Diagnostics, Pioneer in High-tech Cancer Diagnostics". Florence. 2016-12-20
A. Menarini Industrie Farmaceutiche Riunite S.r.l.. (9/11/13). "Press Release: Once Cell in One Billion – the New Italian Technology for Attacking Cancer. Menarini Acquires Silicon Biosystems". Florence. 2013-09-11
Aadi Bioscience, Inc.. (5/8/17). "Press Release: Aadi Bioscience Closes $23 Million in Series A Funding". Pacific Palisades, CA. 2017-05-08
Aastrom Biosciences, Inc.. (4/21/14). "Press Release: Aastrom Announces Definitive Agreement to Acquire Sanofi’s Cell Therapy and Regenerative Medicine Business". Ann Arbor, MI. 2014-04-21
AAVLife. (4/15/14). "Press Release: AAVLife Raises $12 Million in Series A Financing to Advance Gene Therapy for Friedreich’s Ataxia". Paris. 2014-04-15
AB Science S.A.. (11/14/13). "Press Release: Issue of New Shares". Paris. 2013-11-14
AB Science S.A.. (2/27/15). "Press Release: Quarterly Information – Fourth quarter 2014. Turnover up 10% Compared to 2013 Fourth Quarter". Paris. 2015-02-27
AB Science S.A.. (3/27/17). "Press Release: AB Science Announces the Success of a Private Placement [Not for US, CA or JP]". Paris. 2017-03-27
AB Science S.A.. (3/31/17). "Press Release: AB Science Announces the Success of a Private Placement [Not for US, CA or JP]". Paris. 2017-03-31
AB Science S.A.. (4/18/16). "Press Release: AB Science Announces the Success of a Private Placement [Not for Distriubution, Publication, Release, Directly or Indirectly, in the United States, Canada, Australia or Japan]". Paris. 2016-04-18
AB Science S.A.. (4/30/15). "Press Release: 2014 Revenues of 2,099 K€. Clinical Trial with Masitinib in 13 Phase 3 Studies". Paris. 2015-04-30
AB Science S.A.. (5/12/17). "Press Release: AB Science Announces that ANSM Requested the Temporary Suspension of Clinical Studies Conducted in France Following Deviations from Good Clinical Practice (GCP) Standards". Paris. 2017-05-12
AB Science S.A.. (7/24/13). "Press Release: AB Science and Its Partners Receive EUR 8.6 Million as Part of a Project Supported by Bpifrance in Alzheimer’s Disease". 2013-07-23
AB Science S.A.. (8/31/15). "Press Release: Turnover of 1,260K€ in the First Half of 2015, Up 23% when Compared with the First Half of 2014". Paris. 2015-08-31
AB Science S.A.. (9/16/15). "Press Release: Masitinib Receives Orphan Drug Designation for Stomach Cancer from FDA". Paris. 2015-09-16
AB Science S.A.. (9/21/15). "Press Release: AB Science Announces Cessation of Its Rheumatoid Arthritis Study in Order to Focus on Clinical Studies with a Probability of Success Greater than 50%". Paris. 2015-09-21
AB Science S.A.. (9/29/16). "Press Release: Filing of Masitinib in the Treatment of Amyotrophic Lateral Sclerosis (ALS) to the European Medicines Agency (EMA)". Paris. 2016-09-29
AB Sciex (d/b/a Sciex). (10/27/16). "Press Release: Scientists Eradicate Leukemic Stem Cells by Targeting Cell Survival Proteins. Sciex Mass Spectrometry-based Solutions Lead to Leukemia Breakthroughs". Framingham, MA. 2016-10-27
AB Sciex (d/b/a Sciex). (10/28/15). "Press Release: Sciex Partners with University of Manchester to Develop Biomarker Discovery Centre and Multi-Omics Centre for Precision Medicine". Framingham, MA. 2015-10-28
AB Sciex (d/b/a Sciex). (11/09/17). "Press Release: New Method for the Detection of Fipronil Insecticide and Its Associated Metabolites in Eggs and Poultry Launched by Sciex". Warrington. 2017-11-09
AB Sciex (d/b/a Sciex). (12/18/17). "Press Release: Sciex and NofaLab Collaboration Delivers Robust and Sensitive Method for Detecting Multiple Pesticides in a Single Run". Warrington, UK. 2017-12-18
AB Sciex (d/b/a Sciex). (3/2/15). "Press Release: Sciex and Labor Berlin Collaboration to Advance Forensic Testing". Framingham, MA & Darmstadt. 2015-03-02
AB Sciex (d/b/a Sciex). (3/22/17). "Press Release: Sciex Presents Novel QTOF Mass Spectrometry System for Simpler and Faster Biotherapeutics Characterisation". Darmstadt. 2017-03-22
AB Sciex (d/b/a Sciex). (4/10/18). "Press Release: Sciex Launches the Citrine Triple Quad MS/MS Systems in Europe, Bringing Maximal Speed and Sensitivity to Clinical Diagnostics Testing". Darmstadt. 2018-04-10
AB Sciex (d/b/a Sciex). (4/27/15). "Press Release: Experts in Pharma, Clinical Research, Omics, Environmental and Food Testing Meet for SCIEX’s 6th LC-MS/MS Symposium in Berlin". Darmstadt. 2015-04-27
AB Sciex (d/b/a Sciex). (4/7/16). "Press Release: Sciex Sponsored Award Acknowledges Exceptional Contributions to the Field of Electrodriven Separation Techniques. Arnold O. Beckman Medal and Award Presented to Dr. Bohuslav Gaš". Framingham, MA. 2016-04-07
AB Sciex (d/b/a Sciex). (5/18/15). "Press Release: Sciex and the National University of Singapore Faculty of Science Sign a Memorandum of Understanding to Accelerate Cancer Biomarker Discovery in Southeast Asia". Singapore. 2015-05-18
AB Sciex (d/b/a Sciex). (6/1/17). "Press Release: Sciex Announces Innovative Solutions for Customer Success Across Markets at ASMS 2017". Framingham, MA. 2017-06-01
AB Sciex (d/b/a Sciex). (6/1/17). "Press Release: Sciex Launches Its Unrivalled Swath Data Independent Acquisition Technology for Comprehensive Analysis of Food, Forensic and Environmental Samples". Framingham, MA. 2017-06-01
AB Sciex (d/b/a Sciex). (6/13/16). "Press Release: The University of Manchester and Sciex to Open the £18m Stoller Biomarker Discovery Centre on June 14th". Framingham, MA & Manchester. 2016-06-13
AB Sciex (d/b/a Sciex). (6/28/16). "Press Release: Sciex Works with the Francis Crick Institute and the University of Cambridge to Establish the Most Comprehensive Understanding of Metabolism To-date". Framingham, MA. 2016-06-28
AB Sciex (d/b/a Sciex). (6/28/16). "Press Release: The University of Manchester and Sciex Opened the £18m Stoller Biomarker Discovery Centre on June 14th". Framingham, MA & Manchester. 2016-06-28
AB Sciex (d/b/a Sciex). (7/22/15). "Press Release: New Method Addresses the Need for Increased Sensitivity in Halal Meat Authentication to Support Halal Certifications". Framingham, MA. 2015-07-22
AB Sciex (d/b/a Sciex). (7/27/17). "Press Release: Sciex Equipment Is Now Available Through a Wide Range of Flexible Financing Packages via Evosciences". Warrington. 2017-07-27
AB Sciex (d/b/a Sciex). (8/25/16). "Press Release: Sciex to Introduce Benchtop High Resolution Mass Spec for Forensic Toxicology Analysis at TIAFT 2016 Meeting in Brisbane, Australia, Aug 28 – Sep 1, 2016". Singapore. 2016-08-25
AB Sciex (d/b/a Sciex). (8/26/15). "Press Release: Sciex QTRAP 6500 LC-MS/MS System Demonstrates Exceptional Sensitivity and Selectivity in Method Development". Framingham, MA. 2015-08-26
AB Sciex (d/b/a Sciex). (9/13/17). "Press Release: Meet Sciex and Learn about Industrialized Biomarker Research Using SWATH Acquisition at HUPO 2017". Framingham, MA. 2017-09-13
AB Sciex (d/b/a Sciex). (9/15/17). "Press Release: Sciex Announces the Appointment of Inese Lowenstein as President. Former President Jean-Paul Mangeolle to Retire". Framingham, MA. 2017-09-15
AB Sciex (d/b/a Sciex). (9/6/17). "Press Release: Sciex PA 800 Plus Continues to Deliver Quality Results for Ultimate Confidence in Biologics Characterization Data". Framingham, MA. 2017-09-06
AB Sciex (d/b/a Sciex). (9/8/17). "Press Release: Sciex Launches the Topaz LC-MS/MS System for Clinical Diagnostics in Europe". Warrington, UK. 2017-09-08
AB Sciex. (1/17/13). "Press Release: Mobile Laboratory on European MASStastic Voyage Tour to Roll in 2013 with Analytical Tools from AB Sciex, Phenomenex and Peak Scientific". Framingham, MA, Torrance, CA & Billerica, MA. 2013-01-17
AB Sciex. (1/22/15). "Press Release: European Reference Laboratory Improves Accuracy of Pesticide Detection in Food with AB SCIEX Mass Spectrometry Instrumentation". Warrington. 2015-01-22
AB Sciex. (1/28/14). "Press Release: Halal Meat Authenticity Testing Reassures Consumers of No Pig or Horse Contamination. New LC/MS/MS-based Meat Speciation Method". Framingham, MA. 2014-01-28
AB Sciex. (10/2/14). "Press Release: AB Sciex and Illumina Collaborate to Create World’s First Multi-omics Cloud-computing Environment. Integration of SWATH Apps with BaseSpace". Framingham, MA & San Diego, CA. 2014-10-02
AB Sciex. (10/26/11). "Press Release: AB Sciex Advances Food Safety by Mass Spectrometry with the Industry’s First Verified Method for Allergen Testing". Framingham, MA. 2011-10-26
AB Sciex. (10/4/10). "Press Release: ETH Zurich Develops the World’s First Proteomics MRM Atlas with QTRAP Technology from AB Sciex. Online Database of Mass Spectrometry-based Assays to Accelerate Protein Analysis". Foster City, CA. 2010-10-04
AB Sciex. (11/13/14). "Press Release: Germany’s Swimming Professor Chooses AB Sciex QTRAP Technology for Ground-breaking Rhine River Water Decontamination". Darmstadt. 2014-11-13
AB Sciex. (11/8/12). "Press Release: AB Sciex, Phenomenex and Peak Scientific Take Mobile Laboratory on European MASStatic Voyage Tour. Mobile Lab Will Stop at EBF Conference in Barcelona Next Week to Demonstrate LC/MS/MS Workflows". Framingham, MA. 2012-11-08
next pagenext page 1 2 3 ... 168 169 170  next pagenext page



Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

» top